From: Genetic generalized epilepsy: factors associated with drug resistance polytherapy
Intractable | P value | OR | 95% CI | |
---|---|---|---|---|
Lower | Upper | |||
Age at onset | 0.451 | 0.975 | 0.914 | 1.041 |
Nocturnal seizures | 0.805 | 1.106 | 0.495 | 2.472 |
Number of seizure types | 0.361 | 1.301 | 0.739 | 2.291 |
Seizure frequency (GTC) before treatment (number in year) | < 0.001 | 1.113 | 1.057 | 1.171 |
Absence seizures | 0.005 | 0.409 | 0.209 | 0.796 |
H\O CAE | 0.339 | 0.346 | 0.039 | 3.051 |
Catamenial seizures (female) | < 0.001 | 8.085 | 2.786 | 23.464 |
Clusters | 0.143 | 1.915 | 0.803 | 4.566 |
Valproate dose till first remission | < 0.001 | 1.0029 | 1.0020 | 1.0039 |
EEG focal features | 0.197 | 0.376 | 0.085 | 1.664 |